Bioness is the leading provider of innovative technologies helping people regain mobility and independence. Bioness solutions include external and implantable functional electrical stimulation (FES) systems, robotic systems and software based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries. Mission: Bioness provides neuromodulation technologies that help improve lives and restore function for those living with neurological deficit and peripheral pain.
201 to 500Type
Company - PrivateRevenue
$50 to $100 million (USD) per yearIndustry
Biotech & PharmaceuticalsCompetitors